Tal Raviv, MD In 2014, the most common combination of perioperative cataract surgery eye drops—at least among my peers—included a steroid, an NSAID, and a fourth-generation fluoroquinolone antibiotic. However, over…

Tal Raviv, MD I’m happy to write this piece as a follow-up to my September/October 2014 ME article, Patient Check-In: Is It Time To Go Digital? In that column, I…

Tal Raviv, MD The past few Hot Topics columns have centered on utilizing technology to improve digital patient interaction with regard to making online appointments and payments for balances due.…

Tal Raviv, MD We consumers purchase everything online. Really, almost everything. Some of those purchases are as easy as pressing a button on our smartphones (Uber) or using an app…

Tal Raviv, MD As refractive cataract surgeons, we are perennially evaluating the ever-expanding smorgasbord of high-tech diagnostic equipment—from topographers to biometers and more. But in recent months, I’ve added two…

Tal Raviv, MD From the pursuit of perfect surgical outcomes to the art of the patient conversation, mobile apps are gaining increased utility in the modern ophthalmic practice. Described and…

Tal Raviv, MD In a few months’ time—July of 2015—my colleague Robert Weinstock, MD, will be sponsoring what may be the first ophthalmology fellowship focusing exclusively on refractive cataract surgery.…

Tal Raviv, MD Cataracts frequently coexist with other ocular comorbidities, and, in the modern history of the procedure, it was common to perform cataract surgery in combination with other procedures.…